The PIK3CA (PIK3CA encodes p110α) mutation is an oncogenic mechanism associated with PI3K pathway over-activation in BC, which over-activates p110α, enhances PIP2 phosphorylation, and increases PIP3 accumulation, resulting in sustained downstream pathway activation [14]. The gene discussed is PIK3CA; the disease is breast cancer.